Skip to main content
. 2020 Jun 26;20:1009. doi: 10.1186/s12889-020-09136-z

Table 1.

Sociodemographic and clinical characteristics of the study population, by hospitalization status and overall

Variables Number of participants (%) Hospitalisation (%) Non-hospitalisation (%) P-value*
Total participants 672 (100) 388 (57.7) 284 (42.3)
Age (years) 0.030
  < 60 514 (76.5) 285 (55.4) 229 (44.6)
  ≥ 60 158 (23.5) 103 (65.2) 55 (34.8)
Gender 0.376
 Male 432 (64.3) 244 (56.5) 188 (43.5)
 Female 240 (35.7) 144 (60.0) 96 (40.0)
Education 0.927
 None 70 (10.4) 41 (58.6) 29 (41.4)
 Primary or Junior school 368 (54.8) 210 (57.1) 158 (42.9)
 Senior school or above 234 (34.8) 137 (58.5) 97 (41.5)
Floating population 0.004
 No 437 (65.0) 270 (61.8) 167 (38.2)
 Yes 235 (35.0) 118 (50.2) 117 (49.8)
Minimum living security household 0.355
 No 640 (95.2) 367 (57.3) 273 (42.7)
 Yes 32 (4.8) 21 (65.6) 11 (34.4)
Residence 0.486
 Rural 316 (47.0) 178 (56.3) 138 (43.7)
 Urban 356 (53.0) 210 (59.0) 146 (41.0)
Employment status before illness 0.002
 Employed 422 (62.8) 224 (53.1) 198 (46.9)
 Unemployed 250 (37.2) 164 (65.6) 86 (34.4)
Employment status after illness < 0.001
 Employed 386 (57.4) 250 (64.8) 136 (35.2)
 Unemployed 286 (42.6) 138 (48.3) 148 (51.7)
Local basic medical insurance 0.024
 No 212 (31.5) 109 (51.4) 103 (48.6)
 Yes 460 (68.5) 279 (60.7) 181 (39.3)
Household economic status 0.011
 Q1 135 (20.1) 74 (54.8) 61 (45.2)
 Q2 163 (24.3) 100 (61.3) 63 (38.7)
 Q3 157 (23.4) 82 (52.2) 75 (47.8)
 Q4 95 (14.1) 47 (49.5) 48 (50.5)
 Q5 122 (18.2) 85 (69.7) 37 (30.3)
Patient delay 0.263
 No 312 (46.4) 173 (55.4) 139 (44.6)
 Yes 360 (53.6) 215 (59.7) 145 (40.3)
Diagnosis delay 0.196
 No 583 (86.8) 331 (56.8) 252 (43.2)
 Yes 89 (13.2) 57 (64.0) 32 (36.0)
Type of case 0.002
 New or never treated 601 (89.4) 335 (55.7) 266 (44.3)
 Relapse or previously treated 71 (10.6) 53 (74.6) 18 (25.4)
Comorbidities < 0.001
 No 584 (86.9) 315 (53.9) 269 (46.1)
 Yes 88 (13.1) 73 (83.0) 15 (17.0)
Seeking medical care outside the city 0.001
 No 587 (87.4) 325 (55.4) 262 (44.6)
 Yes 85 (12.6) 63 (74.1) 22 (25.9)
Severe adverse drug reactions 0.018
 No 481 (71.6) 264 (54.9) 217 (45.1)
 Yes 191 (28.4) 124 (64.9) 67 (35.1)
Drug sensitivity test 0.002
 RS 586 (87.2) 324 (55.3) 262 (44.7)
 RMR 30 (4.5) 20 (66.7) 10 (33.3)
 MDR 56 (8.3) 44 (78.6) 12 (21.4)

Note: Floating population refers to a group of migrants without Hukou registered in the place where they live or work

Minimum living security household is defined as a household’s anuual income per capita lower than US$ 1429. The designation of minimum living security household status needs to be certified by the local civil affairs bureau

Local basic medical insurance refers to the basic medical insurance registered in Ningbo city

Household economic status is ranked based on a household’s annual income per capita, with quartile 1 (Q1) being the richest and quartile 5 (Q5) being the poorest

Patient delay is determined as a time interval from the first onset of tuberculosis symptoms to the first visit to any health provider lasts for > 14 days

Diagnostic delay is defined as a time interval between a patient’s first visit to any health provider and the final diagnosis as TB lasts for > 14 days

Comorbidities refers to the simultaneous occurrence of malignancy, diabetes mellitus, renal disease, etc.

RS rifampicin-susceptible; RMR rifampicin-monoresistant; MDR multidrug-resistant

*the Chi-square tests were applied to assess differences between categories of variables